
### [NCIT:C4834](http://purl.obolibrary.org/obo/NCIT_C4834)
**Label:** Primary Bone Osteosarcoma

**Subclasses:** [NCIT:C8969](http://purl.obolibrary.org/obo/NCIT_C8969) (Parosteal Osteosarcoma), [NCIT:C6589](http://purl.obolibrary.org/obo/NCIT_C6589) (Childhood Parosteal Osteosarcoma), [NCIT:C6710](http://purl.obolibrary.org/obo/NCIT_C6710) (Stage II Osteosarcoma  AJCC v7), [NCIT:C6701](http://purl.obolibrary.org/obo/NCIT_C6701) (Stage IV Osteosarcoma  AJCC v7), [NCIT:C136633](http://purl.obolibrary.org/obo/NCIT_C136633) (Osteosarcoma by AJCC v7 Stage), [NCIT:C6612](http://purl.obolibrary.org/obo/NCIT_C6612) (Stage III Osteosarcoma  AJCC v7), [NCIT:C4021](http://purl.obolibrary.org/obo/NCIT_C4021) (Chondroblastic Osteosarcoma), [NCIT:C7134](http://purl.obolibrary.org/obo/NCIT_C7134) (Bone Surface (Peripheral) Osteosarcoma), [NCIT:C6470](http://purl.obolibrary.org/obo/NCIT_C6470) (Multifocal Osteosarcoma), [NCIT:C8970](http://purl.obolibrary.org/obo/NCIT_C8970) (Periosteal Osteosarcoma), [NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma), [NCIT:C6590](http://purl.obolibrary.org/obo/NCIT_C6590) (Childhood Conventional Osteosarcoma), [NCIT:C35870](http://purl.obolibrary.org/obo/NCIT_C35870) (Conventional Osteosarcoma), [NCIT:C123398](http://purl.obolibrary.org/obo/NCIT_C123398) (Childhood Periosteal Osteosarcoma), [NCIT:C53958](http://purl.obolibrary.org/obo/NCIT_C53958) (High Grade Surface Osteosarcoma), [NCIT:C53953](http://purl.obolibrary.org/obo/NCIT_C53953) (Osteoblastic Osteosarcoma), [NCIT:C6709](http://purl.obolibrary.org/obo/NCIT_C6709) (Stage I Osteosarcoma  AJCC v7), 

**Class expressions from DL-Learner:**

- Thing 53.58%
- [CL:0000062](http://purl.obolibrary.org/obo/CL_0000062) (osteoblast) 52.50%
- [NCIT:C36900](http://purl.obolibrary.org/obo/NCIT_C36900) (Neoplastic Osteoblast) 40.36%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40122](http://purl.obolibrary.org/obo/NCIT_C40122) (Pelvic Pain))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 37.86%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 37.86%


